The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients
Authors
Keywords
miR-34a, <em class=EmphasisTypeItalic >c</em>-<em class=EmphasisTypeItalic >MET</em>, <em class=EmphasisTypeItalic >Cyclin</em>-<em class=EmphasisTypeItalic >dependent kinase 6</em>, Adenocarcinoma of the lung
Journal
TUMOR BIOLOGY
Volume 36, Issue 12, Pages 9327-9337
Publisher
Springer Nature
Online
2015-06-24
DOI
10.1007/s13277-015-3428-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression
- (2014) M. T. Marino et al. ANNALS OF ONCOLOGY
- TP53 Promoter Methylation in Primary Glioblastoma: Relationship with TP53 mRNA and Protein Expression and Mutation Status
- (2014) Dorota Jesionek-Kupnicka et al. DNA AND CELL BIOLOGY
- Small RNA combination therapy for lung cancer
- (2014) W. Xue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer
- (2013) Sang-Won Hong et al. CANCER LETTERS
- Nuclear expression of CDK4 correlates with disease progression and poor prognosis in human nasopharyngeal carcinoma
- (2013) Qingping Jiang et al. HISTOPATHOLOGY
- Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis
- (2013) Arash Javeri et al. MEDICAL ONCOLOGY
- Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence
- (2013) Danae Papadogianni et al. TUMOR BIOLOGY
- Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
- (2012) Yao Dai et al. BMC CANCER
- miRNA-34 Prevents Cancer Initiation and Progression in a Therapeutically Resistant K-ras and p53-Induced Mouse Model of Lung Adenocarcinoma
- (2012) A. L. Kasinski et al. CANCER RESEARCH
- MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer
- (2012) Yan Lu et al. CARCINOGENESIS
- Detection of miR-34a Promoter Methylation in Combination with Elevated Expression of c-Met and -Catenin Predicts Distant Metastasis of Colon Cancer
- (2012) H. Siemens et al. CLINICAL CANCER RESEARCH
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop
- (2011) Zanobia A Syed et al. BMC CANCER
- miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy
- (2011) Fumihiko Nakatani et al. JOURNAL OF PATHOLOGY
- Elevated expression of CDK4 in lung cancer
- (2011) Aibing Wu et al. Journal of Translational Medicine
- MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells
- (2011) Yanjie Guo et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner
- (2011) Nora Bandi et al. Molecular Cancer
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
- (2011) G Mudduluru et al. ONCOGENE
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- Effect of c-Met inhibitor SU11274 on hepatocellular carcinoma cell growth
- (2011) Yoshinori Inagaki et al. BioScience Trends
- Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis
- (2010) Wen Gao et al. BIOMEDICINE & PHARMACOTHERAPY
- Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
- (2010) J. F. Wiggins et al. CANCER RESEARCH
- Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
- (2010) Dmitri Lodygin et al. CELL CYCLE
- microRNA-34a is tumor suppressive in brain tumors and glioma stem cells
- (2010) Fadila Guessous et al. CELL CYCLE
- MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer
- (2010) M. T. Landi et al. CLINICAL CANCER RESEARCH
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
- (2009) Elena Gallardo et al. CARCINOGENESIS
- MicroRNAs in Cancer
- (2008) Yong Sun Lee et al. Annual Review of Pathology-Mechanisms of Disease
- Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest
- (2008) Fang Sun et al. FEBS LETTERS
- miR-34a repression of SIRT1 regulates apoptosis
- (2008) M. Yamakuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started